← Leaderboards
Michelle Medeiros
University Of Maryland Baltimore
$6,090,564
Attributed
$6,465,562
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2017–23$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,715,565 · 1
FDA$749,997 · 2
By mechanism
N01$5,715,565 · 1
U01$749,997 · 2
Top collaborators
- Claudia Rose Baquet1 shared
- C. Daniel Mullins1 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Karen L. Kotloff$76,457,208
- David A Rasko$17,902,903
- Marcelo B. Sztein$36,733,861
- Robert J Bloch$16,742,827
- James B Kaper$25,841,976
Others in their field
Other Emerging Leaders on “Combat”
- John Damon Chodera · Sloan-Kettering Inst Can Research$33,555,942
- Greg Witham · Anp Technologies, Inc.$19,727,817
- Bruce Blough · Research Triangle Institute$19,637,160
- Ryan Cirz · Revagenix, Inc.$17,912,826
- Robert Frenck · Cincinnati Childrens Hosp Med Ctr$14,263,734
- Jurgen Bernd Bulitta · State University Of New York At Buffalo$12,646,803
Research focus
CombatCommunicable DiseasesConduct Clinical TrialsContractsDesignEvaluationVaccinesVaccine TrialPertussis VaccineProgramsResourcesNamed GroupSpecial Population
Grant awards (6)
Community-Defined Measures to Bridge Health Equity Gaps for COVID-19: Small Town and Rural Needs$499,998
U01 · FY2023 · FD · contact PI
Developing InnoVative Equity-focused Regulatory SciencE (DIVERSE)$249,999
U01 · FY2023 · FD
Vaccine and Treatment Evaluation Unit:Phase II Pertussis Vaccine Trial$537,930
N01 · FY2022 · AI · contact PI
Vaccine and Treatment Evaluation Unit:Phase II Pertussis Vaccine Trial$191
N01 · FY2019 · AI · contact PI
Vaccine and Treatment Evaluation Unit:Phase II Pertussis Vaccine Trial$2,314,767
N01 · FY2018 · AI · contact PI
Vaccine and Treatment Evaluation Unit:Phase II Pertussis Vaccine Trial$2,862,677
N01 · FY2017 · AI · contact PI